More Study Urged on Risks, Benefits of Earlier HIV Therapy

Published: July 15, 2010

THURSDAY, July 15 (HealthDay News) — Among HIV patients with a high level of CD4 immune cells, those who aren’t taking antiretroviral therapy have a moderately increased risk of death, a new study has found.

The researchers said their findings point to the need for continuing studies to examine the risks and benefits of starting antiretroviral therapy, or ART, for patients with high CD4 cell counts.

As HIV infection progresses, CD4 cell levels decrease. Currently, treatment with ART is recommended when a patient’s CD4 count drops below 350 cells per microliter.

Full text of article available at link below –

Leave a Reply